[Agranulocytosis and intravenous cloxacillin]

Area of Science:

• Pharmacology
• Hematology
• Immunology

Background:

• Parenteral antibiotics are crucial for treating severe infections.
• Cloxacillin is a penicillinase-resistant penicillin antibiotic.
• Blood dyscrasias are potential adverse effects of certain medications.

Observation:

• Two patients undergoing parenteral cloxacillin therapy presented with agranulocytosis.
• Agranulocytosis is a severe reduction in white blood cells (specifically granulocytes).

Findings:

• Discontinuation of cloxacillin led to a rapid recovery of leukocyte counts in both patients.
• The observed pattern suggests a direct link between cloxacillin administration and the development of agranulocytosis.

Implications:

• An immunologic mechanism is likely responsible for cloxacillin-induced agranulocytosis.
• This finding highlights the importance of monitoring blood counts in patients receiving cloxacillin.
• Further research into the immunologic pathways of drug-induced blood dyscrasias is warranted.